Genomics and traditional Chinese medicine: A new driver for novel molecular-targeted personalized medicine?

Current Pharmacogenomics and Personalized Medicine

Volumn 10, Issue 1, 2012, Pages 16-21

  Yun, Hongmin ^b   Hou, Lifang ^c,g   Song, Manshu ^g   Wang, Youxin ^g   Zakus, David ^e   Wu, Liuxin ^f   Wang, Wei ^a,d,g  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e UNIVERSITY OF ALBERTA   (Canada)

^f Institute of Air Force Command   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Asia Pacific drug discovery; Genomics; Global public health; Modernization of TCM; Personalized medicine; TCM; Traditional Chinese medicine

Indexed keywords

17 ACETOXYJOLKINOLIDE B; ARTEMISININ; ARTESUNATE; BERBERINE; ENZYME INHIBITOR; GINSENOSIDE; HERBACEOUS AGENT; IRINOTECAN; PHY 906; ROYAL JELLY; TAMOXIFEN; TIAN XIAN WAN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHINESE MEDICINE; DEVELOPING COUNTRY; DNA MICROARRAY; DRUG ANTAGONISM; DRUG TARGETING; ENZYME INHIBITION; EVIDENCE BASED PRACTICE; FUNCTIONAL PROTEOMICS; GENOMICS; HEALTH CARE; HERB; HUMAN; MOLECULARLY TARGETED THERAPY; MUSHROOM; NONHUMAN; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHARMACOEPIDEMIOLOGY; PHENOTYPE;

EID: 84860307691     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111201010016     Document Type: Article

References (32)

1. Yu F, Takahashi T, Moriya J, et al. Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res 2006; 34(3): 231-9.
2. Hon CC, Chow YC, Zeng FY, et al. Genetic authentication of ginseng and other traditional Chinese medicine. Acta Pharmacol Sin 2003; 24(9): 841-6.
3. Konoshima T, Takasaki M, Tokuda H, et al. Anti-tumor-promoting activities of triterpenoids from ferns. I. Biol Pharm Bull 1996; 19(7): 962-5.
4. Ho IS, Leung FC. Isolation and characterization of repetitive DNA sequences from Panax ginseng. Mol Genet Genomics 2002; 266(6): 951-61.
5. Shaw PC, But PP. Authentication of Panax species and their adulterants by random-primed polymerase chain reaction. Planta Med 1995; 61(5): 466-9.
6. Fushimi H, Komatsu K, Isobe M, et al. Application of PCR-RFLP and MASA analyses on 18S ribosomal RNA gene sequence for the identification of three Ginseng drugs. Biol Pharm Bull 1997; 20(7): 765-9.
7. Ngan F, Shaw P, But P, et al. Molecular authentication of Panax species. Phytochemistry 1999; 50(5): 787-91.
8. Cheng WY, Wu SL, Hsiang CY, et al. Relationship Between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. Am J Chin Med 2008; 36(4): 783-97.
9. Mishima S, Suzuki KM, Isohama Y, et al. Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol 2005; 101(1-3): 215-20.
10. Suzuki KM, Isohama Y, Maruyama H, et al. Estrogenic activities of Fatty acids and a sterol isolated from royal jelly. Evid Based Complement Alternat Med 2008; 5(3): 295-302.
11. Liang KW, Yin SC, Ting CT, et al. Berberine inhibits plateletderived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Eur J Pharmacol 2008; 590(1-3): 343-54.
12. Wen Z, Wang Z, Wang S, et al. Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One 2011; 6(3): e18278.
13. Yue PY, Mak NK, Cheng YK, et al. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007; 2: 6.
14. Konkimalla VB, Blunder M, Korn B, et al. Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide 2008; 19(2): 184-91.
15. Yan SS, Li Y, Wang Y, et al. 17-Acetoxyjolkinolide B irreversibly inhibits IkappaB kinase and induces apoptosis of tumor cells. Mol Cancer Ther 2008; 7(6): 1523-32.
16. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 2002; 60(3): 258-74.
17. Jiang J, Sliva D. Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol 2010; 37(6): 1529-36.
18. Kaptchuk T. The holistic logic of Chinese medicine. Sci Dig 1982; 90(11): 32-4.
19. Hu M, Wang DQ, Xiao YJ, et al. Herb-drug interactions: methods to identify potential influence of genetic variations in genes encoding drug metabolizing enzymes and drug transporters. Curr Pharm Biotechnol 2011; Oct 31 [Epub ahead of print].
20. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355(9198): 134-8.
21. Lichti-Kaiser K, Staudinger JL. The traditional Chinese herbal remedy tian xian activates pregnane X receptor and induces CYP3A gene expression in hepatocytes. Drug Metab Dispos 2008; 36(8): 1538-45.
22. Wang E, Bussom S, Chen J, et al. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med Genomics 2011; 4: 38.
23. Tang H, Wang Y. Metabonomics: a revolution in progress. Progress in Biochemistry and Biophysics 2006; 33(5): 401-17
24. Liu P, Liu S, Tian D, et al. The applications and obstacles of metabonomics in traditional chinese medicine. Evid Based Complement Alternat Med 2012; 2012: 945-824.
25. Joshi K, Ghodke Y, Shintre P. Traditional medicine and genomics. J Ayurveda Integr Med 2010; 1(1): 26-32.
26. Zhang A, Sun H, Wang P, et al. Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach. Complementary Ther Med 2011; doi:10.1016/ j.ctim.2011.10.007
27. Salter B, Cooper M, Dickins A. China and the global stem cell bioeconomy: an emerging political strategy? Regen Med 2006; 1(5): 671-83.
28. Han Q, Chen L, Evans T, et al. China and global health. Lancet 2008; 372(9648):1439-41.
29. Khoury MJ, Gwinn M, Burke W, et al. Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med 2007; 33(4): 310-7.
30. Ling RE, Liu F, Lu QX, Wang W. Emerging Issues in Public health: a perspective on China's healthcare system. Public Health 2010; 125(1): 9-14.
31. Yan YX, Liu YQ, Li M, et al. Development and evaluation of a questionnaire for measuring suboptimal health status in urban Chinese. J Epidemiol 2009; 19 (6): 333-41.
32. Yan YX, Do J, Liu YQ, et al. Associaiton of suboptimal health status and cardiovascular risk factors in urban Chinese workers. J Urban Health. 2011; doi10.1007/s11524-011-9636-8